As the third member of the TP53 apoptosis stimulating protein family, its role is to inhibit the anti-tumor effect of the other two members (ASPP1 and ASPP2), leading to abnormal cell proliferation and carcinogenesis (Li et al., 2024). This evidence concerns the gene PPP1R13B and neoplasm.